Cargando…

Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers

INTRODUCTION: The usefulness of smartphone-based application software as a way to manage adverse events (AEs) after vaccination is well known. The purpose of this study is to clarify the usefulness and precautions of employing a smartphone application for collecting AEs after the administration of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Shingo, Watanabe, Kenta, Okuda, Yoshio, Urushihara, Misao, Koshikawa, Hiromi, Chiba, Hitoshi, Yahaba, Misuzu, Taniguchi, Toshibumi, Nakada, Taka-aki, Nakajima, Hiroshi, Ishii, Itsuko, Igari, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885303/
https://www.ncbi.nlm.nih.gov/pubmed/35248497
http://dx.doi.org/10.1016/j.jiac.2022.02.020
Descripción
Sumario:INTRODUCTION: The usefulness of smartphone-based application software as a way to manage adverse events (AEs) after vaccination is well known. The purpose of this study is to clarify the usefulness and precautions of employing a smartphone application for collecting AEs after the administration of Comirnaty®️. METHODS: Healthcare workers (HCWs) who were vaccinated with Comirnaty®️ were asked to register for the application software and to report AEs for 14 days after vaccination. AEs were self-reported according to severity. The software was set to output an alert in case of fever. RESULTS: The number of HCWs who received the first dose was 2,551, and 2,406 (94.3%) reported their vaccinations. 2,547 received the second dose, and 2,347 (92.1%) reported their vaccinations. With the first dose, the reporting rate stayed above 83.3% until the final day. On the other hand, that of the second dose decreased rapidly after 6 days. The most frequent symptom was “pain at injection site” (more than 70%). Severe AEs were 6.6% after the second dose, with 0.6% visiting a clinic. Many AEs peaked on the day after administration and disappeared within 1 week. There were few reports of fever. CONCLUSION: Smartphone applications can be used to collect information on AEs after vaccination. Application settings and dissemination are necessary to maintain the reporting rate of HCWs.